GSA CAPITAL PARTNERS LLP - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 72 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q3 2016. The put-call ratio across all filers is 0.34 and the average weighting 0.6%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q3 2021$104,000
-54.0%
26,143
-50.4%
0.01%
-56.0%
Q2 2021$226,000
+1.8%
52,749
-6.7%
0.02%
-3.8%
Q4 2019$222,000
+91.4%
56,542
+350.0%
0.03%
+100.0%
Q2 2019$116,000
-83.4%
12,565
-88.5%
0.01%
-81.7%
Q1 2019$700,000
+93.9%
108,892
+184.4%
0.07%
+69.0%
Q4 2018$361,000
+22.8%
38,292
+279.4%
0.04%
+180.0%
Q2 2018$294,000
-26.3%
10,092
-24.6%
0.02%
-28.6%
Q1 2018$399,000
-70.0%
13,392
-67.6%
0.02%
-74.1%
Q4 2017$1,332,000
+331.1%
41,392
+365.5%
0.08%
+285.7%
Q3 2017$309,000
-57.0%
8,892
-80.2%
0.02%
-47.5%
Q2 2016$718,000
+52.8%
44,900
+99.6%
0.04%
+33.3%
Q1 2016$470,00022,5000.03%
Other shareholders

There were no reported owners of LA JOLLA PHARMACEUTICAL CO in Q3 2016.

NameSharesValueWeighting ↓
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders